Analysis of Mel-18 expression in prostate cancer tissues and correlation with clinicopathologic features. (Q47939350)

6 February 2018

title

Analysis of Mel-18 expression in prostate cancer tissues and correlation with clinicopathologic features. (English)

1 reference

6 February 2018

author name string

Wei Wang

1

1 reference

6 February 2018

Tianxin Lin

2

1 reference

6 February 2018

Jian Huang

3

1 reference

6 February 2018

Weilie Hu

4

1 reference

6 February 2018

Kewei Xu

5

1 reference

6 February 2018

Jun Liu

6

1 reference

6 February 2018

publication date

22 April 2009

1 reference

6 February 2018

published in

Urologic Oncology

1 reference

6 February 2018

volume

29

1 reference

6 February 2018

issue

3

1 reference

6 February 2018

page(s)

244-251

1 reference

6 February 2018

Polycomb silencers control cell fate, development and cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.004

The bmi-1 and mel-18 gene products define a new family of DNA-binding proteins involved in cell proliferation and tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.004

Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.004

Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.004

Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.004

Cumulative association of five genetic variants with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.004

Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.004

Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.004

Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.004

Role of polycomb group proteins in stem cell self-renewal and cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.004

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.004

The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.004

Cloning and chromosome mapping of the human Mel-18 gene which encodes a DNA-binding protein with a new 'RING-finger' motif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.004

Mel-18 negatively regulates INK4a/ARF-independent cell cycle progression via Akt inactivation in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.004

Molecular markers of prostate cancer outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.004

Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.004

10.1016/J.UROLONC.2009.02.004

7 January 2021

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

19395284

1 reference

6 February 2018